Butterfly Network, Inc. (BFLY) Q3 2024 Earnings Call Transcript Summary
Butterfly Network, Inc. (BFLY) Q3 2024 Earnings Call Transcript Summary
Adjusted The following is a summary of the Butterfly Network, Inc. (BFLY) Q3 2024 Earnings Call Transcript:
以下是Butterfly Network, Inc. (BFLY) Q3 2024业绩会实录摘要:
Financial Performance:
金融业绩：
Butterfly Network reported Q3 2024 revenue of $20.6 million, marking a 33% year-over-year increase.
Gross profit increased to $12.2 million, up 30% from the previous year, although gross margin percentage slightly decreased to 59.5%.
Adjusted EBITDA loss improved by 33% to $8.4 million from a loss of $12.5 million year-over-year.
They anticipate Q4 2024 revenue to be in the range of $20 to $22 million with an expected adjusted EBITDA loss of $10 to $12 million.
Butterfly Network报告了2024年第三季度营业收入为2060万美元，同比增长33%。
毛利润增加至1220万美元，比去年同期增长30%，尽管毛利率略微下降至59.5%。
调整后的EBITDA亏损从去年1250万美元的亏损减少33%至840万美元。
他们预计2024年第四季度营业收入将在20到2200万美元区间内，预计调整后的EBITDA亏损为10到1200万美元。
Business Progress:
业务进展：
Introduced four strategic pillars during an Investor Day including accelerating core business growth, advancing R&D, expanding into new markets, and improving operational efficiency.
Launched iQ3 domestically and internationally, and implemented the ScanLab AI training app.
Established partnerships and expanded into new markets including Indonesia, Netherlands, Belgium, and more.
Announced the formation of Octiv, a subsidiary focused on licensing and commercializing ultrasound technology.
在投资者日引入了四个战略支柱，包括加速核心业务增长，推动研发，进军新市场，以及提高运营效率。
在国内和国际推出了iQ3，并实施了ScanLab 人工智能训练应用程序。
建立了合作伙伴关系，并扩展到印度尼西亚、荷兰、比利时等新市场。
宣布成立Octiv，这是一家侧重于许可和商业化超声技术的子公司。
Opportunities:
机会：
Expansion into home care services with a pilot for virtual chronic care management services starting in Q4 2024, targeting the Medicare advantage provider segment.
Launched iQ3 internationally, broadening the product's global reach and aiming for revenue growth in 2025 from higher average selling prices and additional probes in distribution.
Developing proprietary Butterfly iQ Station and forthcoming P5 chip technologies for entering ultrasound cart markets.
扩展到家庭护理服务，从2024年第四季度开始试点虚拟慢性护理管理服务，目标是Medicare优势提供商领域。
在国际上推出了iQ3，扩大了产品的全球影响力，并旨在通过更高的平均售价和分布渠道中的其他探针实现2025年营业收入增长。
开发专有的Butterfly iQ Station和即将推出的P5芯片技术，以进入超声波设备市场。
Risks:
风险：
Consumer acceptance and market penetration for new product launches like iQ3 and upcoming technologies could affect future revenue projections.
Dependency on strategic partnerships and international market expansions that involve complex regulatory and market dynamics.
消费者对新产品发布的接受程度和市场渗透，如iQ3和即将推出的技术，可能会影响未来的营业收入预测。
依赖战略合作伙伴关系和涉及复杂监管和市场动态的国际市场扩张。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由AI生成。文章内容的准确性无法完全保证。有关更全面的详细信息，请参阅IR网站。本文只是为投资者提供参考，没有任何指导或推荐建议。
